Chaoyue Chen

796 total citations
17 papers, 452 citations indexed

About

Chaoyue Chen is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Chaoyue Chen has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Chaoyue Chen's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and interferon and immune responses (2 papers). Chaoyue Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and interferon and immune responses (2 papers). Chaoyue Chen collaborates with scholars based in China, Ukraine and South Korea. Chaoyue Chen's co-authors include Suyu Sun, Yong Pan, Yin Lin, Xuejiao Cai, Guiqing He, Xingzhong Hu, Yu Fu, Meihui Tao, Xi Zhao and Wei Yan and has published in prestigious journals such as Hepatology, Journal of Medicinal Chemistry and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Chaoyue Chen

14 papers receiving 448 citations

Peers

Countries citing papers authored by Chaoyue Chen

Since Specialization

Citations

This map shows the geographic impact of Chaoyue Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaoyue Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaoyue Chen more than expected).

Fields of papers citing papers by Chaoyue Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaoyue Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaoyue Chen. The network helps show where Chaoyue Chen may publish in the future.

Co-authorship network of co-authors of Chaoyue Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chaoyue Chen. A scholar is included among the top collaborators of Chaoyue Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaoyue Chen. Chaoyue Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Developmentally endothelial locus-1 facilitates intestinal inflammation resolution by suppressing the Cmpk2-cGAS-STING pathway and promoting reparatory macrophage transition 2025 ·Journal of Advanced Research ·Meihui Tao, Li Wang, Chaoyue Chen, (unknown), Yanping Wang, (unknown), Xi Zhao, (unknown), Junfa Chen, Wei Yan, Rong Lin, Yu Fu	0
2	Discovery of Novel 2,4,5-Trisubstituted Pyrimidine Derivatives as Potent and Selective FGFR Inhibitors against Gatekeeper Mutants for the Treatment of NSCLC 2025 ·Journal of Medicinal Chemistry ·Jianxia Zhang, Yi Wang, Mengying Wang, Peipei Wang, (unknown), (unknown), (unknown), Bin Li, Chaoyue Chen, Di Cao, Xiaohui Zheng, Xiaokun Li, Kun Wang, Zhiguo Liu	3
3	Anticancer and chemo-sensitizing effects of annonacin via p53-mediated DNA damage in ovarian cancer 2025 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Jianbo Tong, Zijun Li, (unknown), Chaoyue Chen, Li Wan, Wenyan Ma, (unknown), Namki Cho, (unknown)	0
4	Design, synthesis, and biological evaluation of Flavokavain B derivatives as potent TRF2 inhibitors for the treatment of Osteosarcoma 2025 ·European Journal of Medicinal Chemistry ·Kun Wang, Changgui Shi, Lu Liu, (unknown), (unknown), (unknown), Jianbo Tong, (unknown), Yue‐Qing Hu, Chaoyue Chen, Di Cao, Fangjun Zhang, Xiaohui Zheng, Zhiguo Liu	0
5	Harmine alleviates LPS-induced acute lung injury by inhibiting CSF3-mediated MAPK/NF-κB signaling pathway 2025 ·Respiratory Research ·Yihui Zhai, Kejie Chen, (unknown), (unknown), Jianbo Tong, (unknown), Chaoyue Chen, (unknown), Guang Liang, Xiaohui Zheng	1
6	Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1 2024 ·Bioorganic Chemistry ·(unknown), (unknown), Xiaojian Chen, (unknown), (unknown), Peipei Wang, Chaoyue Chen, Kun Wang, Zhiguo Liu, Xiaohui Zheng	1
7	New sights of immunometabolism and agent progress in colitis associated colorectal cancer 2024 ·Frontiers in Pharmacology ·Jingyue Zhang, Chaoyue Chen, Wei Yan, Yu Fu	5
8	NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies 2023 ·Antioxidants ·Chaoyue Chen, Wei Yan, Meihui Tao, Yu Fu	22
9	Epigenetic modification of m6A methylation: Regulatory factors, functions and mechanism in inflammatory bowel disease 2023 ·The International Journal of Biochemistry & Cell Biology ·Yanping Wang, Chaoyue Chen, Wei Yan, Yu Fu	3
10	STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage 2023 ·International Immunopharmacology ·(unknown), (unknown), Xuejia Yang, (unknown), Yuanyuan Gao, Jiawei Chen, Lili Xie, Chaoyue Chen, Yangyang Guo, Yongheng Bai	17
11	Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells 2022 ·Cell Death Discovery ·(unknown), Yanyi Xiao, (unknown), (unknown), Jiawei Chen, Chaoyue Chen, Mengsi Wang, Lili Xie, (unknown), Tong Yu, Qiyu Zhang, Yongheng Bai	28
12	Atrial Natriuretic Peptide Attenuates Colitis via Inhibition of the cGAS-STING Pathway in Colonic Epithelial Cells 2022 ·International Journal of Biological Sciences ·Chaoyue Chen, Ying Zhang, Meihui Tao, Xi Zhao, (unknown), (unknown), Yu Fu	40
13	Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis 2021 ·Infection and Drug Resistance ·Chaoyue Chen, (unknown), Xi Zhao, Meihui Tao, Wei Yan, Yu Fu	24
14	Clinical Features and Factors Associated with Occult Gastrointestinal Bleeding in COVID-19 Patients 2021 ·Infection and Drug Resistance ·Xi Zhao, Meihui Tao, Chaoyue Chen, (unknown), Yu Fu	3
15	A survey of a COVID-19 cluster of charter flight importation 2021 ·Public Health ·Yong Yue, Yong Chen, Xu Du, Ying Jin, Min Hu, Xiaojuan Jiang, Cheng Wang, (unknown), Longxiang Su, Chaoyue Chen, Shan Jiang, Xianguo Tuo	1
16	Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study 2020 ·Hepatology ·Yu Fu, Rui Zhu, Tao Bai, Ping Han, Qin He, (unknown), Xiaofeng Xiong, Xi Zhao, (unknown), Chaoyue Chen, Ying Zhang, Meihui Tao, Jianhua Yi, Dean Tian, Wei Yan	68
17	Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China 2020 ·Clinica Chimica Acta ·Suyu Sun, Xuejiao Cai, (unknown), Guiqing He, Yin Lin, (unknown), Chaoyue Chen, Yong Pan, Xingzhong Hu	236

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact